
L'OCCITANE (00973.HK) -0.150 (-0.451%) Short selling $8.28K; Ratio 0.028% 's FY2024 revenue growth was in line with expectations, UBS released a research report saying.
Operating margin excluding exceptional impact of impairments and share of profits or losses of associates was also in line with expectations. Therefore, UBS rated the Group at Neutral, with a target price of $30.6.
Related NewsCiti Hikes L'OCCITANE (00973.HK) TP to $34; Annual COP In Line
L'OCCITANE's management expects low teen sales growth and a 1 ppt improvement in operating margins in FY2025, according to the report. In terms of medium term guidance, sales are forecasted to grow at a CAGR of 12-14%, and operating margin is expected to recover to nearly 15% by FY2027.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2024-06-24 16:25.)
AAStocks Financial News
Promoting the development of lithium and sodium in the new energy industry
More than 20 A-share companies will be at risk of delisting!
Is Xiaohongshu's major shareholder selling shares valued at 20 billion?
TikTok "refugees" move to Xiaohongshu. How long will this craze last?
Check whenever you want
WikiStock APP